{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:13:59Z","timestamp":1776258839588,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/jcpt.12579","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T04:22:43Z","timestamp":1497586963000},"page":"530-538","source":"Crossref","is-referenced-by-count":15,"title":["A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients"],"prefix":"10.1155","volume":"42","author":[{"given":"L. P.","family":"Leonart","sequence":"first","affiliation":[{"name":"Department of Pharmacy; Universidade Federal do Paran\u00e1; Curitiba Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. S.","family":"Tonin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Universidade Federal do Paran\u00e1; Curitiba Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. L.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Universidade Federal do Paran\u00e1; Curitiba Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. T. S.","family":"Penteado","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Universidade Federal do Paran\u00e1; Curitiba Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wiens","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Universidade Federal do Paran\u00e1; Curitiba Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. A.","family":"Motta","sequence":"additional","affiliation":[{"name":"Faculdades e Instituto de Pesquisa Pel\u00e9 Pequeno Pr\u00edncipe; Hospital Pequeno Pr\u00edncipe; Curitiba Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4363","authenticated-orcid":false,"given":"R.","family":"Pontarolo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Universidade Federal do Paran\u00e1; Curitiba Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"10.1111\/jcpt.12579-BIB0001|jcpt12579-cit-0001","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clinthera.2013.11.010","article-title":"Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis","volume":"36","author":"Ziakas","year":"2014","journal-title":"Clin Ther"},{"key":"10.1111\/jcpt.12579-BIB0002|jcpt12579-cit-0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0140930","article-title":"Meta-analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia","volume":"10","author":"Fung","year":"2015","journal-title":"Plos One"},{"key":"10.1111\/jcpt.12579-BIB0003|jcpt12579-cit-0003","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0004|jcpt12579-cit-0004","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0005|jcpt12579-cit-0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11046-014-9755-3","article-title":"Epidemiology of invasive fungal infections in patients with acquired immunodeficiency syndrome at a reference hospital for infectious diseases in Brazil","volume":"178","author":"Oliveira","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1111\/jcpt.12579-BIB0006|jcpt12579-cit-0006","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1439-0507.2007.01421.x","article-title":"Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital","volume":"50","author":"Shen","year":"2007","journal-title":"Mycoses"},{"key":"10.1111\/jcpt.12579-BIB0007|jcpt12579-cit-0007","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10096-014-2287-4","article-title":"Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs","volume":"34","author":"Wang","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0008|jcpt12579-cit-0008","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.4081\/pr.2012.e9","article-title":"Epidemiology, risk factors and therapy of candidemia in pediatric hematological patients","volume":"4","author":"Cugno","year":"2012","journal-title":"Pediatr Rep"},{"key":"10.1111\/jcpt.12579-BIB0009|jcpt12579-cit-0009","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","article-title":"Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers","volume":"44","author":"Colombo","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/jcpt.12579-BIB0010|jcpt12579-cit-0010","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.23441","article-title":"Changes in causes of death over time after treatment for invasive aspergillosis","volume":"112","author":"Wingard","year":"2008","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12579-BIB0011|jcpt12579-cit-0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0609.2011.01682.x","article-title":"Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy","volume":"87","author":"Cornely","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1111\/jcpt.12579-BIB0012|jcpt12579-cit-0012","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0013|jcpt12579-cit-0013","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12879-015-0855-6","article-title":"Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients","volume":"15","author":"Bow","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0014|jcpt12579-cit-0014","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","article-title":"Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Flowers","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12579-BIB0015|jcpt12579-cit-0015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1586\/eri.10.85","article-title":"Updated guidelines for managing fungal diseases in hematology patients","volume":"8","author":"Hicheri","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/jcpt.12579-BIB0016|jcpt12579-cit-0016","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"10.1111\/jcpt.12579-BIB0017|jcpt12579-cit-0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/jcpt.12579-BIB0018|jcpt12579-cit-0018","first-page":"263","article-title":"Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient","volume":"24","author":"Barberan","year":"2011","journal-title":"Rev Esp Quimioter"},{"key":"10.1111\/jcpt.12579-BIB0019|jcpt12579-cit-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2011.03477.x","article-title":"Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)","volume":"17","author":"Ruiz-Camps","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/jcpt.12579-BIB0020|jcpt12579-cit-0020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0021|jcpt12579-cit-0021","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/imj.12600","article-title":"Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014","volume":"44","author":"Chau","year":"2014","journal-title":"Intern Med J"},{"key":"10.1111\/jcpt.12579-BIB0022|jcpt12579-cit-0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkt329","article-title":"Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review","volume":"69","author":"Pechlivanoglou","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12579-BIB0023|jcpt12579-cit-0023","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/AAC.01985-15","article-title":"Network meta-analysis and pharmacoeconomic evaluation of fluconazole, itraconazole, posaconazole, and voriconazole in invasive fungal infection prophylaxis","volume":"60","author":"Zhao","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12579-BIB0024|jcpt12579-cit-0024","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","article-title":"Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis","volume":"25","author":"Robenshtok","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1111\/jcpt.12579-BIB0025|jcpt12579-cit-0025","first-page":"CD004707","article-title":"Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia","author":"Jorgensen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jcpt.12579-BIB0026|jcpt12579-cit-0026","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/jcpt.12579-BIB0027|jcpt12579-cit-0027","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins","year":"2011"},{"key":"10.1111\/jcpt.12579-BIB0028|jcpt12579-cit-0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1111\/jcpt.12579-BIB0029|jcpt12579-cit-0029","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jval.2011.01.011","article-title":"Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2","volume":"14","author":"Hoaglin","year":"2011","journal-title":"Value Health"},{"key":"10.1111\/jcpt.12579-BIB0030|jcpt12579-cit-0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1111\/jcpt.12579-BIB0031|jcpt12579-cit-0031","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0032|jcpt12579-cit-0032","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bmt.2009.254","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective","volume":"44","author":"Tomblyn","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/jcpt.12579-BIB0033|jcpt12579-cit-0033","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3324\/haematol.11665","article-title":"Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology","volume":"94","author":"Cornely","year":"2009","journal-title":"Haematologica"},{"key":"10.1111\/jcpt.12579-BIB0034|jcpt12579-cit-0034","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12579-BIB0035|jcpt12579-cit-0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12579-BIB0036|jcpt12579-cit-0036","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jcpt.12579-BIB0037|jcpt12579-cit-0037","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"Burik","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0038|jcpt12579-cit-0038","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0002-9343(91)90184-Y","article-title":"Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation","volume":"91","author":"Rousey","year":"1991","journal-title":"Am J Med"},{"key":"10.1111\/jcpt.12579-BIB0039|jcpt12579-cit-0039","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF01716080","article-title":"Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: a single center experience from 1980 to 1995","volume":"24","author":"Laurenzi","year":"1996","journal-title":"Infection"},{"key":"10.1111\/jcpt.12579-BIB0040|jcpt12579-cit-0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","article-title":"Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients","volume":"165","author":"Perfect","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1111\/jcpt.12579-BIB0041|jcpt12579-cit-0041","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/jcpt.12579-BIB0042|jcpt12579-cit-0042","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/jcpt.12579-BIB0043|jcpt12579-cit-0043","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12579","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12579\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:51Z","timestamp":1671818571000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12579","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}